Aspirin protects against heart disease, while COX-2 Inhibitors appear to injure the heart. The studies by Francois et al. (2005 [this Issue of Cell Metabolism]) shed light on two distinct prostaglandin receptors contributing to these conflicting cardiovascular effects
Aspirin has been a commercial drug for over a century, although for most of this history, an underst...
Aspirin has been a commercial drug for over a century, although for most of this history, an underst...
Selective cyclooxygenase-2 (COX-2) inhibitors were initially developed to reduce the gastrointestina...
Aspirin protects against heart disease, while COX-2 Inhibitors appear to injure the heart. The studi...
Aspirin has been a commercial drug for over a century, although for most of this history, an under-s...
Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 in...
Fries S, Grosser T. The cardiovascular pharmacology of COX-2 inhibition. Hematology Am Soc Hematol E...
AbstractNonsteroidal anti-inflammatory drugs (NSAID) inhibit cyclooxygenase (COX) enzymes, which exi...
Since their approval in 1998, the popularity of selective cyclooxygenase-2 (COX2) inhibitors has swu...
The selective COX-2 inhibitors (coxibs) were originally developed to minimise the adverse effects of...
coxibs, were developed to inhibit inflammatory prostaglandins derived from COX-2, while sparing gast...
AbstractThis report confirms evidence that selective nonsteroidal anti-inflammatory drugs (NSAIDs), ...
Since 1998, two selective inhibitors of COX-2 have been approved in many countries for the treatment...
The use of daily aspirin has been proven to be effectivein the primary and secondary prevention of c...
Cyclooxygenase (COX)-1 and COX-2 are centrally important enzymes within the cardiovascular system wi...
Aspirin has been a commercial drug for over a century, although for most of this history, an underst...
Aspirin has been a commercial drug for over a century, although for most of this history, an underst...
Selective cyclooxygenase-2 (COX-2) inhibitors were initially developed to reduce the gastrointestina...
Aspirin protects against heart disease, while COX-2 Inhibitors appear to injure the heart. The studi...
Aspirin has been a commercial drug for over a century, although for most of this history, an under-s...
Grosser T, Fries S, FitzGerald GA. Biological basis for the cardiovascular consequences of COX-2 in...
Fries S, Grosser T. The cardiovascular pharmacology of COX-2 inhibition. Hematology Am Soc Hematol E...
AbstractNonsteroidal anti-inflammatory drugs (NSAID) inhibit cyclooxygenase (COX) enzymes, which exi...
Since their approval in 1998, the popularity of selective cyclooxygenase-2 (COX2) inhibitors has swu...
The selective COX-2 inhibitors (coxibs) were originally developed to minimise the adverse effects of...
coxibs, were developed to inhibit inflammatory prostaglandins derived from COX-2, while sparing gast...
AbstractThis report confirms evidence that selective nonsteroidal anti-inflammatory drugs (NSAIDs), ...
Since 1998, two selective inhibitors of COX-2 have been approved in many countries for the treatment...
The use of daily aspirin has been proven to be effectivein the primary and secondary prevention of c...
Cyclooxygenase (COX)-1 and COX-2 are centrally important enzymes within the cardiovascular system wi...
Aspirin has been a commercial drug for over a century, although for most of this history, an underst...
Aspirin has been a commercial drug for over a century, although for most of this history, an underst...
Selective cyclooxygenase-2 (COX-2) inhibitors were initially developed to reduce the gastrointestina...
DOI
Add to ORKG